6NV2 image
Entry Detail
PDB ID:
6NV2
Title:
14-3-3 sigma with RelA/p65 binding site pS45 in complex with DP005
Biological Source:
Source Organism:
Host Organism:
PDB Version:
Deposition Date:
2019-02-04
Release Date:
2020-05-13
Method Details:
Experimental Method:
Resolution:
1.13 Å
R-Value Free:
0.17
R-Value Work:
0.16
R-Value Observed:
0.16
Space Group:
C 2 2 21
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:14-3-3 protein sigma
Chain IDs:A
Chain Length:236
Number of Molecules:1
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Description:Transcription factor p65
Chain IDs:B (auth: P)
Chain Length:13
Number of Molecules:1
Biological Source:Homo sapiens
Modified Residue
Compound ID Chain ID Parent Comp ID Details 2D Image
CSO A CYS modified residue
Primary Citation
Selectivity via Cooperativity: Preferential Stabilization of the p65/14-3-3 Interaction with Semisynthetic Natural Products.
J.Am.Chem.Soc. 142 11772 11783 (2020)
PMID: 32501683 DOI: 10.1021/jacs.0c02151

Abstact

Natural compounds are an important class of potent drug molecules including some retrospectively found to act as stabilizers of protein-protein interactions (PPIs). However, the design of synthetic PPI stabilizers remains an understudied approach. To date, there are limited examples where cooperativity has been utilized to guide the optimization of a PPI stabilizer. The 14-3-3 scaffold proteins provide an excellent platform to explore PPI stabilization because these proteins mediate several hundred PPIs, and a class of natural compounds, the fusicoccanes, are known to stabilize a subset of 14-3-3 protein interactions. 14-3-3 has been reported to negatively regulate the p65 subunit of the NF-κB transcription factor, which qualifies this protein complex as a potential target for drug discovery to control cell proliferation. Here, we report the high-resolution crystal structures of two 14-3-3 binding motifs of p65 in complex with 14-3-3. A semisynthetic natural product derivative, DP-005, binds to an interface pocket of the p65/14-3-3 complex and concomitantly stabilizes it. Cooperativity analyses of this interaction, and other disease relevant 14-3-3-PPIs, demonstrated selectivity of DP-005 for the p65/14-3-3 complex. The adaptation of a cooperative binding model provided a general approach to characterize stabilization and to assay for selectivity of PPI stabilizers.

Legend

Protein

Chemical

Disease

Primary Citation of related structures